Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer.

MLA

Xiao, Xiao, et al. “Novel Racemosin B Derivatives as New Therapeutic Agents for Aggressive Breast Cancer.” Bioorganic & Medicinal Chemistry, vol. 26, no. 23–24, Dec. 2018, pp. 6096–104. EBSCOhost, https://doi.org/10.1016/j.bmc.2018.11.014.

APA

Xiao, X., Xu, M., Yang, C., Yao, Y., Liang, L.-N., Ed Chung, P., Long, Q., Zacksenhaus, E., He, Z., Liu, S., & Ben-David, Y. (2018). Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer. Bioorganic & Medicinal Chemistry, 26(23–24), 6096–6104. https://doi.org/10.1016/j.bmc.2018.11.014

Chicago

Xiao, Xiao, Mei Xu, Chao Yang, Yao Yao, Li-Na Liang, Philip Ed Chung, Qun Long, et al. 2018. “Novel Racemosin B Derivatives as New Therapeutic Agents for Aggressive Breast Cancer.” Bioorganic & Medicinal Chemistry 26 (23–24): 6096–6104. doi:10.1016/j.bmc.2018.11.014.